The Covid-19 pandemic has ravaged the globe, and its causative agent, SARS-CoV-2,
continues to rage. Prospects of ending this pandemic rest on the development of effective …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of a
global pandemic of coronavirus disease 2019 (COVID-19) that has led to more than 3 …

The global spread of SARS-CoV-2/COVID-19 is devastating health systems and economies
worldwide. Recombinant or vaccine-induced neutralizing antibodies are used to combat the …

Antibody responses against the SARS-CoV-2 Spike protein correlate with protection against
COVID-19. Serum neutralizing antibodies appear early after symptom onset following SARS …

The increasing prevalence of SARS-CoV-2 variants has raised concerns regarding possible
decreases in vaccine efficacy. Here, neutralizing antibody titers elicited by mRNA-based and …

Rapidly spreading variants of SARS-CoV-2 that have arisen in the United Kingdom and
South Africa share the spike N501Y substitution, which is of particular concern because it is …

Vaccine candidates based on spike, the glycoprotein that is essential for host cell entry by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), were being designed …

The SARS-CoV-2 B. 1.621 (Mu) variant emerged in January 2021 and was categorized as a
variant of interest by the World Health Organization in August 2021. This designation …

Objectives The emergence of new variants of concern (VOCs) of severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) around the world significantly complicated the exit …

Abstract Background Coronavirus SARS-CoV-2, the causative agent of COVID-19, has
caused a still evolving global pandemic. Given the worldwide vaccination campaign, the …